Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 12/20 | 0.61 |
| ▸ | AVPR1A | P37288 | 11/20 | 0.61 |
| ▸ | OXTR | P30559 | 4/20 | 0.45 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5272194 | 0.83 | AVPR1A (0.54) | AVPR2AVPR1A | |
| SCHEMBL6990890 | 0.80 | AVPR1A (0.66) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6985203 | 0.80 | AVPR1A (0.61) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6991577 | 0.79 | AVPR1A (0.68) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6994643 | 0.78 | AVPR1A (0.66) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6984078 | 0.78 | AVPR1A (0.69) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6992414 | 0.78 | AVPR1A (0.66) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL7091449 | 0.77 | AVPR1A (0.65) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6991584 | 0.76 | AVPR1A (0.72) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6988967 | 0.76 | AVPR1A (0.69) | AVPR2AVPR1AAVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0811008-B1 | BICYCLIC BENZAZEPINE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | WYETH CORP (US) | 2003-10-01 | — | — | EP | disclosed |
| US-5696112-A | TREATMENT OF CONGESTIVE HEART FAILURE, CORONARY VASOCONSTRICTION | AMERICAN CYANAMID COMPANY (US) | 1997-12-09 | — | — | US | disclosed |
| US-5654297-A | CONGESTIVE HEART FAILURE, CARDIOVASCULAR DISORDERS | AMERICAN CYANAMID COMPANY (US) | 1997-08-05 | — | — | US | disclosed |
| WO-1996022294-A1 | BICYCLIC BENZAZEPINE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | AMERICAN CYANAMID COMPANY (US) | 1996-07-25 | — | — | WO | disclosed |